Results 131 to 140 of about 20,877 (183)
Rasburicase vs. allopurinol: mortality in hematological malignancies post anti-hyperuricemic therapy - real-world study. [PDF]
Support Care CancerCairo MS +5 more
europepmc +1 more source
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US.
JAMA DermatolCampbell CN +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
American Journal of Ophthalmology, 1984
We conducted a two-part study to determine whether any positive association between the use of allopurinol and the development of cataracts could be demonstrated. Study 1 included 251 Boston-area patients hospitalized for cataract and 753 matched controls. Two cataract patients were regular allopurinol users as compared with six control patients.
H, Jick, D E, Brandt
openaire +2 more sources
We conducted a two-part study to determine whether any positive association between the use of allopurinol and the development of cataracts could be demonstrated. Study 1 included 251 Boston-area patients hospitalized for cataract and 753 matched controls. Two cataract patients were regular allopurinol users as compared with six control patients.
H, Jick, D E, Brandt
openaire +2 more sources
Dermatologica, 2009
We have tried Allopurinol in the treatment of psoriasis, without having any knowledge of previous publications in this respect. The antigouty drug, which acts inhibiting the xanthine oxidase has proved excellent in 50%, good in 34% and moderate in 16% of the cases treated, independent of the oldness of the process.
P A, Viglioglia +3 more
openaire +2 more sources
We have tried Allopurinol in the treatment of psoriasis, without having any knowledge of previous publications in this respect. The antigouty drug, which acts inhibiting the xanthine oxidase has proved excellent in 50%, good in 34% and moderate in 16% of the cases treated, independent of the oldness of the process.
P A, Viglioglia +3 more
openaire +2 more sources
American Journal of Clinical Dermatology, 2010
Off-label use is common in dermatology, and is inevitable for rare cutaneous diseases such as perforating dermatosis. Allopurinol is traditionally considered to be a drug for hyperuricemia only, but the recent demonstration of its efficacy in congestive heart failure has spurred renewed interest in its application in other clinical specialties.
Tsen-Fang, Tsai, Ting-Yu, Yeh
openaire +2 more sources
Off-label use is common in dermatology, and is inevitable for rare cutaneous diseases such as perforating dermatosis. Allopurinol is traditionally considered to be a drug for hyperuricemia only, but the recent demonstration of its efficacy in congestive heart failure has spurred renewed interest in its application in other clinical specialties.
Tsen-Fang, Tsai, Ting-Yu, Yeh
openaire +2 more sources
Clinical Pharmacology & Therapeutics, 1978
A spectrophotometric assay for measuring allopurinol and oxipurinol has been developed which can detect as little as 5 × 10−8 M of each in serum and urine. With this assay, serum disappearance characteristics of intravenous and orally administered allopurinol have been investigated in man.
K, Hande, E, Reed, B, Chabner
openaire +2 more sources
A spectrophotometric assay for measuring allopurinol and oxipurinol has been developed which can detect as little as 5 × 10−8 M of each in serum and urine. With this assay, serum disappearance characteristics of intravenous and orally administered allopurinol have been investigated in man.
K, Hande, E, Reed, B, Chabner
openaire +2 more sources
The Development of Allopurinol
Archives of Internal Medicine, 1985The Clinical Research Unit (CRU) program of the National Institutes of Health, developed in the late 1950s, proved to be an important innovation in the use of public funds to support medical research. The establishment of these units led to a material improvement in the quality, convenience, and feasibility of many types of investigation involving ...
openaire +2 more sources